Potts et al., 2019 - Google Patents
Technology and Mouse Whole-Embryo Culture toPotts et al., 2019
- Document ID
- 9729632809579721234
- Author
- Potts L
- Sadler T
- Publication year
- Publication venue
- Molecular and Cellular Methods in Developmental Toxicology
External Links
Snippet
In the past few years, new molecular biology techniques have been applied to study the function and expression patterns of particular genes in embryonic development. One such technique, targeted gene disruption, allows researchers to study the function of a particular …
- 238000005516 engineering process 0 title abstract description 25
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1079—Screening libraries by altering the phenotype or phenotypic trait of the host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/346—Spatial arrangement of the modifications having a combination of backbone and sugar modifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Foerst‐Potts et al. | Disruption of Msx‐1 and Msx‐2 reveals roles for these genes in craniofacial, eye, and axial development | |
| JP5922721B2 (en) | Identification of microRNAs involved in the maintenance and regeneration of neuromuscular synapses | |
| Romano et al. | Slug is a mediator of epithelial–mesenchymal cell transformation in the developing chicken heart | |
| JP5248494B2 (en) | Protein, nucleic acid encoding it and related methods of use | |
| EP0889122A2 (en) | Inhibition of DNA Methyltransferase | |
| KR20200006980A (en) | Methods of Generating Genetically Modified Animals | |
| KR102670361B1 (en) | Genome editing for control of gene expression | |
| AU2634800A (en) | Composition and method for (in vivo) and (in vitro) attenuation of gene expression using double stranded rna | |
| US9359607B2 (en) | Methods of diagnosing and treating motor neuron diseases | |
| NO334022B1 (en) | The antisense oligonucleotides (ODN) against SMAD7 and their applications in the medical field | |
| Tolstonog et al. | Isolation of SDS-stable complexes of the intermediate filament protein vimentin with repetitive, mobile, nuclear matrix attachment region, and mitochondrial DNA sequence elements from cultured mouse and human fibroblasts | |
| US20030185829A1 (en) | Jagged 2 inhibitors for inducing apoptosis | |
| Potts et al. | The use of antisense oligonucleotide technology and mouse whole-embryo culture to study gene function during organogenesis | |
| JP4111463B2 (en) | Cell reprogramming method and composition | |
| Meneghetti et al. | Zebrafish ambra1a and ambra1b silencing affect heart development | |
| Potts et al. | Technology and Mouse Whole-Embryo Culture to | |
| JP4427639B2 (en) | Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them | |
| CN107709560A (en) | Treatment method | |
| Parekh-Olmedo et al. | Modified single-stranded oligonucleotides inhibit aggregate formation and toxicity induced by expanded polyglutamine | |
| Eto et al. | Whole embryo culture and the study of postimplantation mammalian development | |
| US6576218B1 (en) | Transplacental delivery of oligonucleotides | |
| Potts | Disruption of Msx-1, Msx-2, and HNF-3 (beta) using antisense oligonucleotide technology and mouse whole embryo culture produces craniofacial and axial malformations | |
| AU2012204034B2 (en) | Proteins, nucleic acids encoding the same and associated methods of use | |
| Walsh | Microglia and Progranulin Regulate Neurogenesis in the Developing Vertebrate Retina. | |
| da Costa | Genetic and developmental studies of neuronal migration defects in the mouse |